CM
Castleark Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-49,580
| Closed | -$2.89M | – | 321 |
|
|
2022
Q2 | $2.89M | Sell |
49,580
-11,080
| -18% | -$646K | 0.15% | 137 |
|
|
2022
Q1 | $4.63M | Buy |
+60,660
| New | +$4.63M | 0.2% | 117 |
|
|
2019
Q1 | – | Sell |
-119,440
| Closed | -$5.14M | – | 394 |
|
|
2018
Q4 | $5.14M | Sell |
119,440
-106,105
| -47% | -$4.56M | 0.22% | 143 |
|
|
2018
Q3 | $11.1M | Buy |
+225,545
| New | +$11.1M | 0.32% | 107 |
|
|
2016
Q1 | – | Sell |
-144,060
| Closed | -$11.1M | – | 403 |
|
|
2015
Q4 | $11.1M | Buy |
+144,060
| New | +$11.1M | 0.33% | 77 |
|
|
2015
Q1 | – | Sell |
-129,325
| Closed | -$11.5M | – | 373 |
|
|
2014
Q4 | $11.5M | Buy |
129,325
+41,986
| +48% | +$3.72M | 0.3% | 96 |
|
|
2014
Q3 | $6.11M | Sell |
87,339
-4,000
| -4% | -$280K | 0.17% | 137 |
|
|
2014
Q2 | $8.39M | Buy |
91,339
+4,000
| +5% | +$367K | 0.23% | 98 |
|
|
2014
Q1 | $6.11M | Sell |
87,339
-39,399
| -31% | -$2.76M | 0.17% | 137 |
|
|
2013
Q4 | $7.29M | Buy |
126,738
+45,902
| +57% | +$2.64M | 0.21% | 88 |
|
|
2013
Q3 | $7.84M | Sell |
80,836
-47,999
| -37% | -$4.65M | 0.22% | 117 |
|
|
2013
Q2 | $3.74M | Buy |
+128,835
| New | +$3.74M | 0.12% | 131 |
|